Effects of Full-Fat and Fermented Dairy Products on Cardiometabolic Disease: Food Is More Than the Sum of Its Parts.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing existing literature without systematic review methodology
PubMed 31518411 · doi:10.1093/advances/nmz069
What was done
The authors conducted a narrative review evaluating the evidence regarding full-fat and fermented dairy products (specifically yogurt and cheese) on cardiometabolic disease risk markers (insulin sensitivity, blood lipid profile, blood pressure) and clinical outcomes (cardiovascular disease, type 2 diabetes) to assess whether guidelines restricting full-fat dairy based on saturated fat content remain supported.
What was found
The abstract reports no numerical data or quantitative effect sizes. It qualitatively synthesizes that full-fat dairy products do not exert detrimental effects on insulin sensitivity, blood lipids, or blood pressure, do not increase cardiometabolic risk, and may protect against cardiovascular disease and type 2 diabetes.
Why it matters
It argues that dietary guidance focusing on single nutrients like saturated fat is outdated compared to a whole-food matrix approach, suggesting recommendations to restrict full-fat dairy should be re-evaluated.
Limits
The abstract provides no sample size, study counts, or quantitative estimates. As a narrative review, it lacks a systematic search protocol, risk-of-bias evaluation, and meta-analytic synthesis. The authors note that further research is required to adjust for confounding factors and resolve underlying mechanisms.
Cited by
- supports Saturated fats consumed in fermented dairy products have been shown to provide metabolic benefits.